Início
Reels
Grupos
Páginas
Ver mais
Grupos Páginas Eventos Blogs Funding
Entrar Cadastrar
Night Mode
What Are the Key Challenges Facing the AAV Vector-based Gene Therapy Market?
Despite its promise, the AAV vector-based gene therapy market faces significant challenges. High treatment costs—often exceeding millions of dollars per patient—raise access and reimbursement concerns. Payers are scrutinizing value, and outcomes-based payment models are being explored. The adeno-associated virus vector-based gene therapy market also faces immunogenicity issues....
0 Comentários ·0 Compartilhamentos ·130 Visualizações ·0 Anterior
Faça o login para curtir, compartilhar e comentar!